M

Mesoblast
MSB

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
A$2.29B
EV
A$2.43B
Shares Outstanding
1.30B
Beta
1.42

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
A$3.50
P/E 2025E
15.75x
P/Revenue 2025E
79.10x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Mesoblast Limited

gainify

M

Mesoblast Limited

MSB

Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. The ...

Sector

Healthcare

Industry

Biotechnology

CEO

Itescu, Silviu

Employees

73

IPO Date

2004-12-15

Headquarters

55 Collins Street, Level 38, Melbourne, Victoria, 3000, Australia

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.